Article
APOBEC and Cancer Viroimmunotherapy: Thinking the Unthinkable.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jun 2021
Vile Richard G, Melcher Alan, Pandha Hardev, Harrington Kevin J, Pulido Jose S
Abstract excerpt
The apolipoprotein B mRNA editing enzyme catalytic polypeptide (APOBEC) family protects against infection by degrading incoming viral genomes through cytosine deamination. Here, we review how the potential to unleash these potent DNA mutagens comes at a price as APOBEC DNA mutagenesis can contribute to development of multiple types of cancer. In addition, because viral infection induces its expression, APOBEC is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
